Search research articles
Contact Us
Filters
Showing results (421-430 of 499) with videos related to
Page
of 50
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)
Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Nature Immunology
|
November 23, 2021
Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques
Edward B Irvine, Anthony O'Neil, Patricia A Darrah, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 2012
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography
Laura E Via, Dan Schimel, Danielle M Weiner, et al.
Pharmaceutical Research
|
September 25, 1999
Assessment of value and applications of in vitro testing of topical dermatological drug products
G L Flynn, V P Shah, S N Tenjarla, et al.
BMC Genomics
|
September 12, 2022
Identification and characterization of the T cell receptor (TCR) repertoire of the cynomolgus macaque (Macaca Fascicularis)
Swati Jaiswal, Sarah K Nyquist, Shayla Boyce, et al.
International Journal of Molecular Sciences
|
July 15, 2026
Suppression of Post-Ischemic Cardiac Remodelling and Inflammatory Response by a Novel Sphingolipid Modifier, CIN038
Bing H Wang, Feby Savira, Xin Xiong, et al.
Nature Microbiology
|
January 10, 2025
A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity
Alexander A Smith, Hongwei Su, Joshua Wallach, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
A "suicide" BCG strain provides enhanced immunogenicity and robust protection against <i>Mycobacterium tuberculosis</i> in macaques
Alexander A Smith, Hongwei Su, Joshua Wallach, et al.
The Journal of Clinical Investigation
|
December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
Philana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2015
A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets
Laura E Via, Kathleen England, Danielle M Weiner, et al.
Page
of 50
Search research articles
Search
Showing results (421-430 of 499) with videos related to
Sort By:
Page
of 50
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)
Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Nature Immunology
|
November 23, 2021
Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques
Edward B Irvine, Anthony O'Neil, Patricia A Darrah, et al.
Antimicrobial Agents and Chemotherapy
|
June 13, 2012
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography
Laura E Via, Dan Schimel, Danielle M Weiner, et al.
Pharmaceutical Research
|
September 25, 1999
Assessment of value and applications of in vitro testing of topical dermatological drug products
G L Flynn, V P Shah, S N Tenjarla, et al.
BMC Genomics
|
September 12, 2022
Identification and characterization of the T cell receptor (TCR) repertoire of the cynomolgus macaque (Macaca Fascicularis)
Swati Jaiswal, Sarah K Nyquist, Shayla Boyce, et al.
International Journal of Molecular Sciences
|
July 15, 2026
Suppression of Post-Ischemic Cardiac Remodelling and Inflammatory Response by a Novel Sphingolipid Modifier, CIN038
Bing H Wang, Feby Savira, Xin Xiong, et al.
Nature Microbiology
|
January 10, 2025
A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity
Alexander A Smith, Hongwei Su, Joshua Wallach, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
A "suicide" BCG strain provides enhanced immunogenicity and robust protection against <i>Mycobacterium tuberculosis</i> in macaques
Alexander A Smith, Hongwei Su, Joshua Wallach, et al.
The Journal of Clinical Investigation
|
December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
Philana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2015
A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets
Laura E Via, Kathleen England, Danielle M Weiner, et al.
Page
of 50